Founded in 2015 by Professor Andrew Mearns Spragg, a Scottish marine biotechnology pioneer, Jellagen is a marine biotechnology company manufacturing Collagen Type 0 for medical and scientific research applications. It is our deep belief in building sustainable sources for critical biomaterials which do not carry the environmental and human health risks of traditional collagen sources.

Since 2015, Jellagen has honed its proprietary technology, enhanced its product range, and extended its expertise.


Today Jellagen is led by a world-class team with experience across pharma, biotech, medical devices and investment banking. They bring strong scientific, clinical, and market development along with excellent commercial and business expertise. View the full Jellagen Team, Management Team, Board and Scientific Advisory Board here.

GreggWeb Gregg Sando Chairman of the Board, Non-Executive Director
Thomas-Paul Descamps Thomas-Paul Descamps CEO, Executive Director
Andrew Mearns-Spragg Professor Andrew Mearns Spragg Founder, CSO, Executive Director

Dr Andy Weymann MD MBA Chief Medical Officer
Stephane Thiroloix Stéphane Thiroloix Non-Executive Director
Berent Wallendahl Berent Wallendahl Non-Executive Director

Steve Fairey Stephen Fairey CFO, Board Observer

Our Collaborators

We know that to create smart and practical innovation we need to harness the knowledge and experience of the best in the world. We collaborate with universities, research laboratories and medical companies both big and small to create solutions that build on knowledge and deliver step changes in the application of collagen.

Our collaborators include: